Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $3.16 billion. The enterprise value is $2.31 billion.

Market Cap	3.16B
Enterprise Value	2.31B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025, after market close.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

VKTX has 112.31 million shares outstanding. The number of shares has increased by 10.50% in one year.

Current Share Class	112.31M
Shares Outstanding	112.31M
Shares Change (YoY)	+10.50%
Shares Change (QoQ)	+0.65%
Owned by Insiders (%)	2.12%
Owned by Institutions (%)	70.39%
Float	109.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.73
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 44.25, with a Debt / Equity ratio of 0.00.

Current Ratio	44.25
Quick Ratio	43.52
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,914.63

Financial Efficiency

Return on equity (ROE) is -14.40% and return on invested capital (ROIC) is -12.08%.

Return on Equity (ROE)	-14.40%
Return on Assets (ROA)	-11.74%
Return on Invested Capital (ROIC)	-12.08%
Return on Capital Employed (ROCE)	-20.33%
Revenue Per Employee	n/a
Profits Per Employee	-$3.56M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.92% in the last 52 weeks. The beta is 0.75, so VKTX's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-56.92%
50-Day Moving Average	26.23
200-Day Moving Average	43.87
Relative Strength Index (RSI)	54.29
Average Volume (20 Days)	2,954,460

Short Selling Information

The latest short interest is 25.54 million, so 22.74% of the outstanding shares have been sold short.

Short Interest	25.54M
Short Previous Month	26.54M
Short % of Shares Out	22.74%
Short % of Float	23.25%
Short Ratio (days to cover)	5.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-172.32M
Pretax Income	n/a
Net Income	-128.24M
EBITDA	n/a
EBIT	-172.32M
Earnings Per Share (EPS)	-$1.15

Full Income Statement

Balance Sheet

The company has $851.86 million in cash and $1.00 million in debt, giving a net cash position of $850.86 million or $7.58 per share.

Cash & Cash Equivalents	851.86M
Total Debt	1.00M
Net Cash	850.86M
Net Cash Per Share	$7.58
Equity (Book Value)	846.92M
Book Value Per Share	7.54
Working Capital	846.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-133.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.50%
Shareholder Yield	-10.50%
Earnings Yield	-4.05%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for VKTX is $84.00, which is 198.30% higher than the current price. The consensus rating is "Buy".

Price Target	$84.00
Price Target Difference	198.30%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1